HomeOVID • NASDAQ
add
Ovid Therapeutics Inc
Previous close
$2.42
Day range
$2.38 - $2.56
Year range
$0.24 - $2.72
Market cap
362.47M USD
Avg Volume
3.42M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 718.00K | 844.74% |
Operating expense | 13.01M | 18.30% |
Net income | 9.66M | 204.44% |
Net profit margin | 1.35K | 111.06% |
Earnings per share | 0.06 | 146.15% |
EBITDA | -12.28M | -14.08% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 25.60M | -51.76% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 44.70M | — |
Shares outstanding | 71.21M | — |
Price to book | 3.84 | — |
Return on assets | — | — |
Return on capital | -52.57% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 9.66M | 204.44% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2014
Website
Employees
23
